Genscript Biotech Corporation (FRA:G51)
1.416
+0.029 (2.13%)
At close: Dec 19, 2025
18.00% (1Y)
| Market Cap | 3.17B |
| Revenue (ttm) | 705.13M |
| Net Income (ttm) | 2.65B |
| Shares Out | n/a |
| EPS (ttm) | 1.20 |
| PE Ratio | 1.20 |
| Forward PE | 34.71 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 15 |
| Open | 1.416 |
| Previous Close | 1.387 |
| Day's Range | 1.416 - 1.416 |
| 52-Week Range | 1.100 - 2.042 |
| Beta | n/a |
| RSI | 35.52 |
| Earnings Date | Mar 10, 2026 |